Thirty eight patients with chronic sputum expectoration underwent indium-ill labelled granulocyte lung scanning and measurement of whole body loss of indium-ill labelled granulocytes. Twenty four patients had radiologically proved bronchiectasis and 14 had mucus hypersecretion without radiological evidence of bronchiectasis. None was having an acute exacerbation at the time of the scan. The median 24 hour volume of sputum expectorated was 17 (range 2-175) ml. The 24 hour volume of purulent sputum was 5 (0-142) ml; six patients expectorated mucoid sputum only. Twenty one of the 38 patients had a positive granulocyte lung scan. All nine patients expectorating more than 20 ml purulent sputum in 24 hours had positive lung scans and all had lost more than 19% of the indium-ill from the body after five to seven days. Of the six patients with mucoid sputum, only one had a positive scan and these subjects lost only 6-11% of the indium-III in five to seven days. The percentage loss of indium-ill from the body correlated with 24 hour purulent sputum volume (r = 0-41, n = 38, p < 0 001) and total elastolytic activity in 24 hour sputum (r = 0-54, n = 14, p < 001). 
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hours and five to seven days. Anterior, posterior, and often lateral oblique views of the chest and views of the abdomen were obtained on each occasion. The lung uptake of "'In and the lobar distribution were recorded from the 20-24 hour images. The lung uptake of "'In was assessed visually by two nuclear medicine physicians and graded as negative or mildly, moderately, or strongly positive. The amount of "'In in the whole body was measured with an uncollimated gamma camera two to five hours after the injection and after five to seven days. The percentage "'In retention after five to seven days was calculated for each patient after correction for isotope decay. The whole body loss of granulocytes was defined as 100 minus the percentage whole body "'In retention at this time. The whole body loss from eight control subjects with no evidence of respiratory disease was on average 50% at five to seven days3 and did not exceed 110%. In patients with a positive "'In granulocyte lung scan and no evidence of inflammatory bowel disease the additional loss of "'In (by comparison with control values) is assumed to be from sputum. The computed tomography and other clinical results were not available at the time the "'In scan was reported.
ANALYSIS
The whole body loss of granulocytes was correlated with other markers of inflammation and the extent of bronchiectasis by means of the non-parametric Kendall's rank correlation.9 Multiple regression analysis was performed with the SPSSX statistics package (Statistical Packages for the Social Sciences, Chicago) to determine the correlation of the 24 hour purulent sputum volume and the number of lobes containing bronchiectasis with the loss of indium labelled granulocytes.
Results

SPUTUM AND HAEMATOLOGICAL MARKERS OF INFLAMMATION
The median 24 hour sputum volume was 17 (range 2-175) ml and the 24 hour purulent sputum volume was 5 (0-142) ml; six of the 38 subjects produced mucoid sputum only. The colour of the purulent portion was green in all cases with an average grade + + (range + to +++). The total elastolytic activity in 14 patients with purulent sputum and bronchiectasis ranged-from 2 to 513 Mg. Serum IgA was raised in 10 of the 14 patients (range 1 2-9-6 (normal 0 7-3 2) g/l) and IgG was raised in four (range 8-9-33 1 (normal 6-4-16) g/l); none had a raised IgM concentration. The erythrocyte sedimentation rate was raised in nine of the 14 cases with a range of 3-51 mm in the first hour. The leucocyte count was raised in only one -patient.
Indium-111 labelled granulocyte scanning to detect inflammation in the lungs ofpatients with chronic sputum expectoration The six patients producing mucoid sputum had lost 6-11% of the "'In by five to seven days; only one of these patients had a positive scan (grade +). The percentage loss of indium-i1 1 from the body correlated with the 24 hour volume of purulent sputum (r = 0-41, n = 38, p < 0-001; fig 2) . The granulocyte scan grade also correlated with 24 hour purulent sputum volume (table 1). Four patients still had a positive granulocyte scan after five to seven days and they had lost less indium (12-20%) than the patients whose scans were positive to a similar extent at 21-24 hours (+ + or + + + grade, "'In loss 21-53"%) but had become negative. Of the 17 patients with a negative granulocyte scan, two lost more "'In than the six subjects producing non-purulent sputum; one of these two patients lost 31 % of the " 'In Table 1 from the body as a result of early bowel activity due to inflammatory bowel disease; the other patient lost 12% of the "'In. These two were also the only patients from the 19 with a low 24 hour purulent sputum volume (up to 5 ml) to lose more "'In than the non-purulent sputum producers. Whole body loss of "'In correlated with total elastolytic activity (r = 0 54, n = 14, p < 0-01) and with serum IgG concentrations (r = 0-41, n = 14, p < 0 05). "'In loss was not significantly correlated with serum immunoglobulin A or M, erythrocyte sedimentation rate, or white blood count.
The number of bronchiectatic lobes was correlated with "'In loss (r = 0-32, n = 36, p < 0 01), though the correlation did not persist after volume of purulent sputum had been entered into the regression analysis. The relation between "'In labelled granulocyte scans and the presence or absence of bronchiectasis on computed tomograms is shown in We conclude that assessment of the migration of "'In labelled granulocytes into the lungs is a useful method ofobjectively monitoring the level of local inflammation in patients expectorating purulent sputum.
